Skip to main content

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Akero Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Akero Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Akero Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Harrison Seth LoringDirector0Dec 9, 20251
Iwicki Mark TDirector0Dec 9, 20251
Henderson JaneDirector0Dec 9, 20251
Gangloff Scott A.Chief Technology Officer0Dec 9, 20251
Graham G. WalmsleyDirector0Dec 9, 20252
Cheng AndrewPresident and CEO0Dec 9, 20255
White William RichardChief Financial Officer0Dec 9, 20251
Yale CatrionaChief Development Officer0Dec 9, 20252
Rolph TimothyChief Scientific Officer0Dec 9, 20254
Young JonathanChief Operating Officer0Dec 9, 20253
Heyman Tomas J.Director0Dec 9, 20251
Xu YuanDirector0Dec 9, 20251
Judy ChouDirector0Dec 9, 20251
Lamy PatrickSee Remarks0Dec 9, 20251
Ezbon International LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Blue Horizon Enterprise LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Montrago Trustees LtdOther: Former 10% owner3,271,829IndirectDec 5, 20220
Skorpios TrustOther: Former 10% owner3,271,829IndirectDec 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 14, 2025 (view filing)Mar 122 daysRolph TimothyChief Scientific OfficerSSale−516$44.88−$23.2K−0.3%169.7K after
Mar 12, 2025 (view filing)Mar 102 daysCheng AndrewPresident and CEOSSale−30.0K$41.77−$1.25M−4.4%656.1K after2 lots10b5-1
Mar 7, 2025 (view filing)Mar 52 daysRolph TimothyChief Scientific OfficerSSale−12.5K$44.53−$556.6K−6.8%170.2K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 41 dayYoung JonathanChief Operating OfficerSSale−50.0K$44.86−$2.24M−19.9%201.1K after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 32 daysLamy PatrickSenior VP, Commercial StrategySSale−1.00K$48.09−$48.1K−2.9%33.5K after10b5-1
Feb 21, 2025 (view filing)Feb 183 daysLateYale CatrionaChief Development OfficerSSale−10.0K$49.87−$498.7K−9.5%95.6K after2 lots10b5-1
Feb 11, 2025 (view filing)Feb 101 dayCheng AndrewPresident and CEOSSale−30.0K$52.73−$1.58M−4.2%686.1K after5 lots10b5-1
Feb 7, 2025 (view filing)Jan 308 daysLateGraham G. WalmsleyDirectorPPurchase+200.0K$48.00+$9.60M+25.0%1.00M after
Feb 7, 2025 (view filing)Feb 52 daysRolph TimothyChief Scientific OfficerSSale−18.8K$56.52−$1.06M−9.9%170.2K after2 lots10b5-1
Feb 5, 2025 (view filing)Feb 32 daysYoung JonathanChief Operating OfficerSSale−10.0K$53.81−$538.1K−3.8%251.1K after2 lots10b5-1
Jan 31, 2025 (view filing)Jan 274 daysLateYale CatrionaChief Development OfficerSSale−53.6K$56.25−$3.01M−35.9%95.6K after3 lots10b5-1
Jan 31, 2025 (view filing)Jan 274 daysLateYale CatrionaChief Development OfficerSSale−49.1K$55.72−$2.73M−33.9%95.6K after3 lots10b5-1
Jan 29, 2025 (view filing)Jan 272 daysRolph TimothyChief Scientific OfficerSSale−31.3K$55.77−$1.74M−15.5%170.2K after3 lots10b5-1
Jan 29, 2025 (view filing)Jan 272 daysLamy PatrickSenior VP, Commercial StrategySSale−5.00K$57.03−$285.1K−13.0%33.5K after10b5-1
Jan 29, 2025 (view filing)Jan 272 daysCheng AndrewPresident and CEOSSale−30.0K$54.90−$1.65M−4.0%716.1K after3 lots10b5-1
Jan 6, 2025 (view filing)Jan 24 daysYoung JonathanChief Operating OfficerSSale−10.0K$28.03−$280.3K−4.4%218.1K after10b5-1
Dec 18, 2024 (view filing)Dec 162 daysLamy PatrickSenior VP, Commercial StrategySSale−1.00K$29.13−$29.1K−2.8%34.3K after10b5-1
Dec 18, 2024 (view filing)Dec 162 daysYale CatrionaChief Development OfficerSSale−9.07K$29.11−$264.1K−8.7%95.6K after10b5-1
Dec 18, 2024 (view filing)Dec 171 dayRolph TimothyChief Scientific OfficerSSale−3.80K$31.10−$118.2K−2.1%178.3K after10b5-1
Dec 12, 2024 (view filing)Dec 102 daysRolph TimothyChief Scientific OfficerSSale−4.82K$30.91−$148.9K−2.6%178.3K after2 lots10b5-1
Dec 12, 2024 (view filing)Dec 102 daysYoung JonathanChief Operating OfficerSSale−2.50K$30.79−$77.1K−1.2%203.8K after
Dec 12, 2024 (view filing)Dec 102 daysLamy PatrickSenior VP, Commercial StrategySSale−925$30.79−$28.5K−4.9%17.9K after
Dec 12, 2024 (view filing)Dec 102 daysYale CatrionaChief Development OfficerSSale−2.81K$30.79−$86.5K−3.8%71.3K after
Dec 12, 2024 (view filing)Dec 102 daysWhite William RichardChief Financial OfficerSSale−2.82K$30.79−$86.7K−6.8%38.3K after
Dec 12, 2024 (view filing)Dec 102 daysCheng AndrewPresident and CEOSSale−7.86K$30.79−$241.9K−1.3%597.6K after
Dec 4, 2024 (view filing)Dec 22 daysCheng AndrewPresident and CEOSSale−25.0K$32.09−$802.3K−4.0%605.4K after10b5-1
Dec 4, 2024 (view filing)Dec 22 daysYoung JonathanChief Operating OfficerSSale−10.0K$32.13−$321.3K−4.6%206.3K after10b5-1
Nov 19, 2024 (view filing)Nov 154 daysYale CatrionaChief Development OfficerSSale−9.06K$27.73−$251.2K−10.9%74.2K after2 lots10b5-1
Nov 8, 2024 (view filing)Nov 62 daysYale CatrionaChief Development OfficerSSale−10.0K$35.19−$351.9K−11.9%74.2K after10b5-1
Nov 5, 2024 (view filing)Nov 14 daysYoung JonathanChief Operating OfficerSSale−50.7K$31.57−$1.60M−19.0%216.3K after3 lots10b5-1
Nov 5, 2024 (view filing)Nov 14 daysCheng AndrewPresident and CEOSSale−108.4K$31.73−$3.44M−15.2%605.4K after2 lots10b5-1
Nov 1, 2024 (view filing)Oct 30-Nov 12 daysYale CatrionaChief Development OfficerSSale−20.0K$32.60−$652.0K−21.2%74.2K after2 lots10b5-1
Oct 18, 2024 (view filing)Oct 16-182 daysCheng AndrewPresident and CEOSSale−91.6K$31.41−$2.88M−13.1%605.4K after4 lots10b5-1
Oct 16, 2024 (view filing)Oct 142 daysYoung JonathanChief Operating OfficerSSale−40.0K$30.15−$1.21M−15.0%226.3K after10b5-1
Oct 16, 2024 (view filing)Oct 14-152 daysYale CatrionaChief Development OfficerSSale−21.0K$30.37−$636.6K−22.0%74.2K after3 lots10b5-1
Oct 3, 2024 (view filing)Oct 12 daysYoung JonathanChief Operating OfficerSSale−10.0K$28.18−$281.8K−4.2%226.3K after10b5-1
Sep 23, 2024 (view filing)Sep 203 daysYale CatrionaChief Development OfficerSSale−5.50K$27.65−$152.1K−6.8%75.3K after10b5-1
Sep 18, 2024 (view filing)Sep 16-182 daysYale CatrionaChief Development OfficerSSale−8.39K$27.55−$231.2K−10.0%75.3K after3 lots10b5-1
Sep 13, 2024 (view filing)Sep 103 daysLateYoung JonathanChief Operating OfficerSSale−568$26.18−$14.9K−0.2%236.3K after
Sep 13, 2024 (view filing)Sep 103 daysLateYale CatrionaChief Development OfficerSSale−637$26.18−$16.7K−0.8%75.3K after
Sep 13, 2024 (view filing)Sep 103 daysLateWhite William RichardChief Financial OfficerSSale−639$26.18−$16.7K−1.5%41.2K after
Sep 13, 2024 (view filing)Sep 103 daysLateRolph TimothyChief Scientific OfficerSSale−537$26.18−$14.1K−0.3%180.7K after
Sep 13, 2024 (view filing)Sep 103 daysLateCheng AndrewPresident and CEOSSale−1.74K$26.18−$45.5K−0.3%605.4K after
Sep 5, 2024 (view filing)Sep 32 daysYoung JonathanChief Operating OfficerSSale−5.00K$26.72−$133.6K−2.1%236.9K after2 lots10b5-1
Sep 5, 2024 (view filing)Sep 32 daysYale CatrionaChief Development OfficerSSale−949$27.61−$26.2K−1.2%75.9K after10b5-1
Aug 29, 2024 (view filing)Aug 26-273 daysLateWhite William RichardChief Financial OfficerSSale−98.3K$27.02−$2.66M−70.2%41.8K after4 lots10b5-1
Aug 28, 2024 (view filing)Aug 23-265 daysLateYale CatrionaChief Development OfficerSSale−14.1K$27.52−$386.7K−15.6%75.9K after2 lots10b5-1
Aug 2, 2024 (view filing)Aug 11 dayYoung JonathanChief Operating OfficerSSale−5.00K$26.75−$133.8K−2.0%241.9K after2 lots10b5-1
Jul 25, 2024 (view filing)Jul 23-252 daysWhite William RichardChief Financial OfficerSSale−161.9K$27.07−$4.38M−79.5%41.8K after5 lots10b5-1
Jul 18, 2024 (view filing)Jul 162 daysWhite William RichardChief Financial OfficerSSale−34.8K$28.05−$976.4K−45.4%41.8K after2 lots10b5-1